Cordyceps Sunshine Biotech Holdings Co., Ltd.
RAJAF · Medicinal Chemicals & Botanical Products · EDGAR filings ↗
Grade
D46Tiny single-product Taiwan mushroom-supplement maker, loss-making with very low cash and going-concern language.
Strengths
- High gross margin 61% (82nd pct) and positive ROE optics (61.5th)
- Near-breakeven operating cash margin relative to sector
Risks
- Net margin -12.4%, declining revenue and net loss; cash only ~$3.2k and current ratio 0.19
- Single-supplier/single-product concentration and explicit going-concern funding need
Notable findings
- Net lossNet loss (net margin -12.4%)
- Weak liquidityCurrent ratio 0.19 (<1)
Key metrics
Gross margin
61.1%
Operating margin
-11.3%
Net margin
-12.4%
Return on equity
29.0%
Return on assets
-3.3%
Revenue growth (QoQ)
-0.6%
Current ratio
0.2×
Tangible book value
-$535K
Cash & investments
$3K
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 20-F | 2026-05-15 | 2025-12-31 | 0001213900-26-057774 ↗ |
| 20-F | 2025-06-13 | 2024-12-31 | 0001213900-25-054317 ↗ |
| 20-F | 2024-07-05 | 2023-12-31 | 0001213900-24-059406 ↗ |
| 20-F | 2023-05-15 | 2022-12-31 | 0001213900-23-039368 ↗ |